Related Experiment Video

Updated: Aug 23, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Fluconazole resistance in Candida albicans: a review of mechanisms

I A Casalinuovo1, P Di Francesco, E Garaci

  • 1Department of Experimental Medicine and Biochemical Sciences, Microbiology, University of Rome Tor Vergata, Rome, Italy.

European Review for Medical and Pharmacological Sciences
|July 23, 2004
PubMed

Insights

Antifungal resistance in Candida albicans is a growing public health concern. This review details fluconazole

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antifungal agents have improved public health, but antifungal resistance is a rising threat.
  • Candida albicans infections cause significant morbidity and mortality, especially in immunocompromised individuals.
  • Fluconazole is a widely used azole antifungal for candidal infections.

Purpose of the Study:

  • To review the antifungal mechanisms of fluconazole.
  • To discuss molecular pathways of fluconazole resistance in Candida albicans.
  • To explore emerging antifungal agents.

Main Methods:

  • Literature review of antifungal mechanisms.
  • Analysis of molecular pathways in antifungal resistance.
  • Discussion of current and novel antifungal therapies.

Main Results:

  • Fluconazole targets ergosterol biosynthesis, crucial for fungal cell membrane integrity.
  • Mechanisms of fluconazole resistance in C. albicans involve altered drug targets, efflux pumps, and metabolic pathways.
  • Several new antifungal agents are under development to combat resistant strains.

Conclusions:

  • Understanding fluconazole resistance mechanisms is vital for effective treatment of candidal infections.
  • Development of new antifungal agents is necessary to address the challenge of antifungal resistance.
  • Continued research into Candida albicans antifungal resistance is critical for public health.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...